A medical weight loss program is clinician-supervised treatment for excess weight that can combine diet plans, behavior support and prescription medicine.
The UCLA program
The UCLA Medical Weight Management Program describes medically supervised low-calorie and very-low-calorie diets, meal replacements and group cognitive behavioral therapy classes [1]. Its overview page does not list a price, so ask what the intake visit, labs, meal replacements and classes each cost, and whether medicine is prescribed and billed separately.
Sponsored placement: open.
One local practice can be featured here. This is a paid, labeled placement and never an endorsement.
Feature your practice in Los Angeles, from $300 a month.
The box is a paid listing. We mark it as sponsored and do not endorse the advertiser. Read how we make money.
Medi-Cal stopped paying for weight-loss GLP-1s in 2026
Angelenos on Medi-Cal lost adult coverage for weight-loss GLP-1s on January 1, 2026, when the state's 2025-26 budget took effect. Two groups keep access: enrollees under 21, and adults whose doctor shows a medical need for another use, type 2 diabetes being the common one [2]. California was one of four states KFF found dropping obesity coverage after October 2025 [6]. Older residents on a Part D plan have a separate route: Medicare's GLP-1 Bridge sets a $50 copay per month for Wegovy, Foundayo or the Zepbound KwikPen until December 31, 2027, for people who meet its BMI rules [7].
A city of 3.9 million, two sets of numbers
CDC PLACES estimates adult obesity at 27.3% in the city and 26.5% in Los Angeles County; diagnosed diabetes is 11.9% in the city and 12.6% countywide [3] [4]. The city has 3,869,089 residents [5]. Large systems include Cedars-Sinai and Keck Medicine of USC; we did not confirm a published weight program or price at either.
What the drug alone costs without insurance
| Product and dose | Per month | Price seen | Source |
|---|---|---|---|
| Wegovy tablet at its first dose | $149 | Oct 17, 2026 | [8] |
| Foundayo tablet, by dose | $149 to $299 | Oct 17, 2026 | [9] |
| Wegovy injection pen | $349 | Oct 17, 2026 | [8] |
| Zepbound 7.5 mg and up, refilled within 45 days | $449 | Oct 17, 2026 | [10] |
Before you enroll anywhere
- Get the total monthly cost in writing: program fee, visits, labs and the drug.
- Ask whether the medicine is an FDA-approved brand or compounded. FDA has warned 30 telehealth companies about illegal marketing of compounded GLP-1s [11].
- Check the prescriber with the Medical Board of California [12].
- Use our clinic checklist and the medical weight loss guide.
Trial averages, not promises
STEP 1 participants on semaglutide 2.4 mg lost an average of 14.9% of body weight at 68 weeks [13]; SURMOUNT-1 participants on tirzepatide 15 mg lost 20.9% at 72 weeks [14]. Individual results differ. Drug-specific pages: semaglutide in Los Angeles and tirzepatide in Los Angeles. Nearby: Orange County, Beverly Hills and San Diego.
Nearby, our Beverly Hills weight loss guide covers the same county with its own local figures.
Safety on prescription weight drugs
Per the Wegovy and Zepbound labels, get medical care for severe abdominal pain that persists, which can mean pancreatitis [15] [16]. Watch for allergic reactions such as facial swelling or trouble breathing, and for low blood sugar if you take insulin or a sulfonylurea. Both drugs have a boxed warning about thyroid C-cell tumors and should not be used with a personal or family history of medullary thyroid carcinoma or MEN 2. Stop when pregnancy is recognized. Call 911 in an emergency.
Questions people ask
Can an adult on Medi-Cal in Los Angeles get Wegovy or Zepbound for weight loss?
Not for weight loss. Starting January 1, 2026, Medi-Cal no longer covers GLP-1s for adult weight loss, though enrollees under 21 keep coverage [2].
What does UCLA's weight management program use?
UCLA Health's Medical Weight Management Program lists supervised low-calorie and very-low-calorie diets, meal replacements and group cognitive behavioral therapy classes [1].
How common is obesity in Los Angeles compared with the county?
What is the lowest self-pay price for a brand GLP-1 in Los Angeles?
Where can I look up a Los Angeles doctor's California license?
The Medical Board of California runs a free license lookup at mbc.ca.gov [12].
Sources
16 cited
- Medical Weight Management Program: program overview. UCLA Health, accessed 2026-10-17.
- California Medicaid ends coverage of GLP-1 drugs for weight loss. KFF Health News, Jan 9, 2026.
- PLACES data, place, 2025 release: Los Angeles, CA. Centers for Disease Control and Prevention, 2025 release (2023 BRFSS).
- PLACES data, county, 2025 release: Los Angeles County, CA. Centers for Disease Control and Prevention, 2025 release (2023 BRFSS).
- QuickFacts: Los Angeles city, California. U.S. Census Bureau, 2025 estimates and 2020-2024 ACS; accessed 2026-10-17.
- Medicaid coverage of and spending on GLP-1s. KFF, Jan 16, 2026.
- Weight loss drugs coverage (Medicare GLP-1 Bridge). Medicare.gov (CMS), accessed 2026-10-17.
- Wegovy self-pay offer, NovoCare Pharmacy. Novo Nordisk (NovoCare), Oct 17, 2026.
- Foundayo self-pay prices on LillyDirect. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
- Zepbound self-pay prices on LillyDirect. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
- FDA warns 30 telehealth companies against illegal marketing of compounded GLP-1s. U.S. Food and Drug Administration, Mar 3, 2026.
- Medical Board of California. State of California, accessed 2026-10-17.
- Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine (PubMed), 2021.
- Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine (PubMed), 2022.
- Wegovy label (injection and tablets). DailyMed, National Library of Medicine, Jun 2026.
- Zepbound (tirzepatide) prescribing information. U.S. Food and Drug Administration, Apr 2026.
This page is general information, not medical advice. Talk with a licensed clinician about your own care.